Wilmington Savings Fund Society FSB grew its holdings in Tenet Healthcare Co. (NYSE:THC – Free Report) by 1,352.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 523 shares of the company’s stock after purchasing an additional 487 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Tenet Healthcare were worth $66,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Plato Investment Management Ltd acquired a new position in Tenet Healthcare during the 3rd quarter valued at about $28,000. Financial Management Professionals Inc. raised its stake in Tenet Healthcare by 2,222.2% in the 3rd quarter. Financial Management Professionals Inc. now owns 209 shares of the company’s stock valued at $35,000 after acquiring an additional 200 shares during the period. True Wealth Design LLC bought a new stake in Tenet Healthcare during the 3rd quarter valued at $38,000. Spire Wealth Management grew its stake in Tenet Healthcare by 19.5% during the fourth quarter. Spire Wealth Management now owns 558 shares of the company’s stock valued at $70,000 after acquiring an additional 91 shares in the last quarter. Finally, Hantz Financial Services Inc. purchased a new stake in shares of Tenet Healthcare in the 3rd quarter valued at about $83,000. 95.44% of the stock is currently owned by institutional investors.
Tenet Healthcare Trading Up 5.4 %
THC opened at $133.02 on Friday. The company has a market cap of $12.65 billion, a P/E ratio of 4.26, a PEG ratio of 0.63 and a beta of 2.05. Tenet Healthcare Co. has a one year low of $87.06 and a one year high of $171.20. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. The business’s 50-day simple moving average is $133.43 and its 200-day simple moving average is $148.26.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. The Goldman Sachs Group downgraded shares of Tenet Healthcare from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $196.00 to $140.00 in a research note on Monday, December 16th. Truist Financial cut their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Monday, January 6th. StockNews.com cut Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday. Barclays reduced their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a report on Thursday. Finally, KeyCorp lowered their price objective on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $163.19.
Get Our Latest Stock Analysis on THC
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- Insider Trading – What You Need to Know
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Compound Interest and Why It Matters When Investing
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What Are Earnings Reports?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.